(Q37140094)

18 August 2017

1 reference

title

Intensive statin therapy in acute coronary syndromes (English)

1 reference

18 August 2017

1 reference

Tze Vun Liew

1

1 reference

18 August 2017

Kausik K Ray

series ordinal

2

1 reference

18 August 2017

publication date

1 April 2008

1 reference

Current Atherosclerosis Reports

18 August 2017

published in

1 reference

18 August 2017

volume

10

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

158-163

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-008-0023-1

18 August 2017

exact match

0 references

cites work

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11883-008-0023-1

Coronary Plaque Disruption

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11883-008-0023-1

Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease

21 January 2018

1 reference

12 December 2020

The Potential Relevance of the Multiple Lipid-Independent (Pleiotropic) Effects of Statins in the Management of Acute Coronary Syndromes

1 reference

12 December 2020

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

1 reference

12 December 2020

Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients

1 reference

12 December 2020

High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial

1 reference

12 December 2020

Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the Hyperlipidemias

1 reference

12 December 2020

C-reactive protein and other inflammatory risk markers in acute coronary syndromes

1 reference

12 December 2020

Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality

1 reference

12 December 2020

Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for ‘pleiotropic’ functions of statin therapy

1 reference

12 December 2020

Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome

1 reference

12 December 2020

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22.

1 reference

12 December 2020

The effects of atorvastatin on coronary endothelial function in patients with recent myocardial infarction.

1 reference

12 December 2020

Pathophysiology of coronary artery disease

1 reference

12 December 2020

Predicting coronary heart disease in middle-aged and older persons. The Framington study

1 reference

12 December 2020

Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial

1 reference

12 December 2020

Elevated plaque temperature in non-culprit de novo atheromatous lesions of patients with acute coronary syndromes

1 reference

12 December 2020

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

1 reference

12 December 2020

The MRC/BHF Heart Protection Study: preliminary results.

1 reference

12 December 2020

Rosuvastatin reduces MMP-7 secretion by human monocyte-derived macrophages: potential relevance to atherosclerotic plaque stability.

1 reference

12 December 2020

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

12 December 2020

Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22)

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial

1 reference

12 December 2020

The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes

1 reference

12 December 2020

High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study

1 reference

12 December 2020

Statins as a newly recognized type of immunomodulator

1 reference

12 December 2020

The nonlipid effects of statins on endothelial function

1 reference

12 December 2020

Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?

1 reference

12 December 2020

C-reactive protein levels and outcomes after statin therapy

1 reference

12 December 2020

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

12 December 2020

Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial

1 reference

12 December 2020

Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial

1 reference

12 December 2020

Role of endothelial dysfunction in atherosclerosis

1 reference

12 December 2020

Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages

1 reference

12 December 2020

Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)

1 reference

12 December 2020

Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

12 December 2020

Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study

1 reference

12 December 2020

Matrix metalloproteinases and atherosclerosis

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

12 December 2020

Beneficial effects of statins on endothelial dysfunction and vascular stiffness

1 reference

12 December 2020

Fluvastatin alters platelet aggregability in patients with hypercholesterolemia: possible improvement of intraplatelet redox imbalance via HMG-CoA reductase.

1 reference

12 December 2020

Atherosclerotic Abdominal Aortic Aneurysm and the Interaction Between Autologous Human Plaque-Derived Vascular Smooth Muscle Cells, Type 1 NKT, and Helper T Cells

1 reference

12 December 2020

Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial

1 reference

12 December 2020

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

12 December 2020

10.1007/S11883-008-0023-1

Identifiers

DOI

1 reference

18 August 2017

1 reference